We are live on ! Find out more
INBS icon

Intelligent Bio Solutions

8 hedge funds and large institutions have $437K invested in Intelligent Bio Solutions in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

0% more funds holding

Funds holding: 8 → 8 (0)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

1% less capital inflows, than outflows

Capital inflows: $328K | Capital outflows: $332K

4.17% less ownership

Funds ownership: 10.11% → 5.94% (-4.2%)

Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

INBS Hedge Fund Activity: Q3 2024 in Review

8 of the 6,991 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q3 2024, worth a combined $437K — down 28% from $606K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new INBS positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $321K. The largest seller was Altium Capital Management, exiting entirely with an estimated $161K sold.

  • 8 institutional investors held Intelligent Bio Solutions (INBS) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $437K of Intelligent Bio Solutions stock for Q3 2024, down 28% quarter-over-quarter.
  • 2 funds opened new Intelligent Bio Solutions positions in Q3 2024 and 1 closed out, a net change of +1 holder.
  • The largest Intelligent Bio Solutions buyer in Q3 2024 was Alyeska Investment Group, an estimated $321K added.
  • The largest Intelligent Bio Solutions seller in Q3 2024 was Altium Capital Management, an estimated $161K sold.

Based on aggregated 13F filings for Q3 2024.